Perspective Therapeutics (CATX) EBT Margin Growth (5y) (2015 - 2023)
Perspective Therapeutics (CATX) EBT Margin Growth (5y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 304.08 Mn | 304.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 23,283.00 |
| Sep 30, 2023 | -37,742.00 |
| Jun 30, 2023 | -59,330.00 |
| Mar 31, 2023 | -50,936.00 |
| Sep 30, 2022 | -10,926.00 |
| Jun 30, 2022 | 5,099.00 |
| Mar 31, 2022 | 5,980.00 |
| Dec 31, 2021 | 8,409.00 |
| Sep 30, 2021 | 5,544.00 |
| Jun 30, 2021 | 15,699.00 |
| Mar 31, 2021 | 7,761.00 |
| Dec 31, 2020 | 7,708.00 |
| Sep 30, 2020 | 5,225.00 |
| Jun 30, 2020 | 2,500.00 |
| Mar 31, 2020 | 6,588.00 |
| Dec 31, 2019 | 4,830.00 |
| Sep 30, 2019 | 6,953.00 |
| Jun 30, 2019 | 8,102.00 |
| Mar 31, 2019 | 2,846.00 |
| Dec 31, 2018 | 2,192.00 |